| Literature DB >> 11336560 |
C Fligge1, T Giroglou, R E Streeck, M Sapp.
Abstract
The immunogenicity of capsomeres of human papillomavirus type 33 was evaluated in a dose-response analysis. Capsomeres were obtained free of capsids by expression of L1 carrying the single point mutation C427S. Neutralizing antibodies were detected using an in vitro pseudoinfection assay. Capsomeres induced type-specific, neutralizing antibodies in mice even in the absence of adjuvant. The neutralization titers of immune sera raised without adjuvant were 10- to 20-fold lower than those of antisera to virus-like particles, but virtually identical using Freund's adjuvant. These data indicate that capsomeres may substitute for virus-like particles in future vaccines when used with an adjuvant appropriate for human vaccination. Copyright 2001 Academic Press.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11336560 DOI: 10.1006/viro.2000.0875
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616